Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lyle Joseph Micheli, M.D.

Co-Author

This page shows the publications co-authored by Lyle Micheli and Benedikt Proffen.
Connection Strength

0.764
  1. Bridge-Enhanced Anterior Cruciate Ligament Repair: Two-Year Results of a First-in-Human Study. Orthop J Sports Med. 2019 Mar; 7(3):2325967118824356.
    View in: PubMed
    Score: 0.208
  2. The Bridge-Enhanced Anterior Cruciate Ligament Repair (BEAR) Procedure: An Early Feasibility Cohort Study. Orthop J Sports Med. 2016 Nov; 4(11):2325967116672176.
    View in: PubMed
    Score: 0.177
  3. The Effect of Perioperative Ketorolac on the Clinical Failure Rate of Meniscal Repair. Orthop J Sports Med. 2014 May 01; 2(5).
    View in: PubMed
    Score: 0.148
  4. Regional Differences in Anterior Cruciate Ligament Signal Intensity After Surgical Treatment. Am J Sports Med. 2021 Oct 20; 3635465211047554.
    View in: PubMed
    Score: 0.062
  5. Higher Physiologic Platelet Counts in Whole Blood Are Not Associated With Improved ACL Cross-sectional Area or Signal Intensity 6 Months After Bridge-Enhanced ACL Repair. Orthop J Sports Med. 2020 Jul; 8(7):2325967120927655.
    View in: PubMed
    Score: 0.057
  6. Females Have Earlier Muscle Strength and Functional Recovery After Bridge-Enhanced Anterior Cruciate Ligament Repair. Tissue Eng Part A. 2020 07; 26(13-14):702-711.
    View in: PubMed
    Score: 0.057
  7. Bridge-Enhanced Anterior Cruciate Ligament Repair Is Not Inferior to Autograft Anterior Cruciate Ligament Reconstruction at 2 Years: Results of a Prospective Randomized Clinical Trial. Am J Sports Med. 2020 05; 48(6):1305-1315.
    View in: PubMed
    Score: 0.056
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.